Menu Search
Equities

Siegfried Holding AG

SQG:BRN

Siegfried Holding AG

Actions
  • Price (CHF)893.62
  • Today's Change0.00 / 0.00%
  • Shares traded9.00
  • 1 Year change+27.70%
  • Beta--
Data delayed at least 15 minutes, as of Apr 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.

  • Revenue in CHF (TTM)1.27bn
  • Net income in CHF112.06m
  • Incorporated1904
  • Employees3.93k
  • Location
    Siegfried Holding AGUntere Bruehlstrasse 4ZOFINGEN 4800SwitzerlandCHE
  • Phone+41 627461111
  • Fax+41 627461102
  • Websitehttps://www.siegfried.ch/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SFZN:SWX since
announced		Transaction
value
DiNAMIQS AGDeal completed04 May 202304 May 2023Deal completed28.06%--
Data delayed at least 15 minutes, as of May 03 2024 09:15 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.